Congenital Hyperinsulinism International (CHI) is a nonprofit 501(c)(3) corporation dedicated to improving the lives of babies, children, and adults affected by congenital hyperinsulinism (HI). HI is a life-threatening genetic disorder that causes severe low blood sugar (hypoglycemia) in infants and children, though in 50% of patients, the genetic cause is unknown. For those with HI, the beta cells of the pancreas secrete too much insulin in an unregulated manner. Excess insulin causes hypoglycemia. Prolonged or severe hypoglycemia can cause seizures, permanent brain damage, or even death if left untreated. A good prognosis is far more likely with a timely diagnosis and proper management.
| Year | Revenue | Expenses | Net Assets |
|---|---|---|---|
| 2024 Form 990 Jan 1, 2024 to Dec 31, 2024 | $1,275,774 ↑ | $1,126,855 | $1,853,453 |
| 2023 Form 990 Jan 1, 2023 to Dec 31, 2023 | $1,150,291 ↓ | $1,043,446 | $1,704,534 |
| 2022 Form 990 Jan 1, 2022 to Dec 31, 2022 | $1,262,625 ↑ | $834,055 | $1,597,689 |
| 2020 Form 990 Jan 1, 2020 to Dec 31, 2020 | $707,807 ↑ | $467,697 | $822,508 |
| 2018 Form 990 Jan 1, 2018 to Dec 31, 2018 | $355,579 | $382,051 | $610,210 |
Sign up free to search 16M+ grants and see similar organizations on every nonprofit profile.
Sign Up FreeNo credit card required.